Ryberg E et al. |
The orphan receptor GPR55 is a novel cannabinoid receptor. |
2007 |
Br. J. Pharmacol. |
pmid:17876302
|
Straiker A et al. |
Differential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neurones. |
2012 |
Br. J. Pharmacol. |
pmid:22014238
|
Woodhams SG et al. |
Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat. |
2012 |
Br. J. Pharmacol. |
pmid:22924700
|
Chicca A et al. |
The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting cannabinoid receptors. |
2012 |
Br. J. Pharmacol. |
pmid:22646533
|
Ho WS and Randall MD |
Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. |
2007 |
Br. J. Pharmacol. |
pmid:17245358
|
Mukhopadhyay P et al. |
CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model. |
2010 |
Br. J. Pharmacol. |
pmid:20590569
|
Gutierrez-Lopez MD et al. |
Involvement of 2-arachidonoyl glycerol in the increased consumption of and preference for ethanol of mice treated with neurotoxic doses of methamphetamine. |
2010 |
Br. J. Pharmacol. |
pmid:20590579
|
Solinas M et al. |
The endocannabinoid system in brain reward processes. |
2008 |
Br. J. Pharmacol. |
pmid:18414385
|
Kerr DM et al. |
The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action. |
2013 |
Br. J. Pharmacol. |
pmid:23043675
|
Bisogno T et al. |
A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects. |
2013 |
Br. J. Pharmacol. |
pmid:23072382
|
Avraham Y et al. |
Capsaicin affects brain function in a model of hepatic encephalopathy associated with fulminant hepatic failure in mice. |
2009 |
Br. J. Pharmacol. |
pmid:19764982
|
Ghafouri N et al. |
Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. |
2004 |
Br. J. Pharmacol. |
pmid:15492019
|
Guindon J et al. |
The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors. |
2007 |
Br. J. Pharmacol. |
pmid:17179944
|
Ho WS et al. |
Endocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex. |
2010 |
Br. J. Pharmacol. |
pmid:20590576
|
Centonze D et al. |
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. |
2007 |
Brain |
pmid:17626034
|
Mulder J et al. |
Molecular reorganization of endocannabinoid signalling in Alzheimer's disease. |
2011 |
Brain |
pmid:21459826
|
Doenni VM et al. |
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling. |
2016 |
Brain Behav. Immun. |
pmid:27453335
|
Mecha M et al. |
Endocannabinoids drive the acquisition of an alternative phenotype in microglia. |
2015 |
Brain Behav. Immun. |
pmid:26086345
|
Avraham Y et al. |
2-Arachidonoylglycerol as a possible treatment for anorexia nervosa in animal model in mice. |
2017 |
Brain Res. |
pmid:28606779
|
Lara-Celador I et al. |
Endocannabinoids reduce cerebral damage after hypoxic-ischemic injury in perinatal rats. |
2012 |
Brain Res. |
pmid:22841538
|